Selonsertib in Combination With Prednisolone Versus Prednisolone Alone in Participants With Severe Alcoholic Hepatitis (AH)

Completed · Phase 2 · Has a placebo group

Conditions studied: Alcoholic Hepatitis (AH)

In brief

The primary objective of this study is to evaluate the safety and tolerability of selonsertib (GS-4997) in combination with prednisolone versus prednisolone alone in participants with severe alcoholic hepatitis (AH).

Key facts

Study ID
NCT02854631
Run by
Gilead Sciences
People needed
104
Starts
2016-09-01
Expected to finish
2018-05-31
Last updated by the study team
2019-02-06

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.